​

bioAffinity (BIAF) Revenue & Revenue Breakdown

OverviewOwnershipFinancialsChart

bioAffinity Revenue Highlights

Latest Revenue (Y)

$9.36M

Latest Revenue (Q)

$1.45M

Main Segment (Y)

Health Care, Patient Service

bioAffinity Revenue by Period

bioAffinity Revenue by Year

DateRevenueChange
2024-12-31$9.36M269.68%
2023-12-31$2.53M52627.44%
2022-12-31$4.80K100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31--

bioAffinity generated $9.36M in revenue during NA 2024, up 269.68% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

bioAffinity Revenue by Quarter

DateRevenueChange
2025-09-30$1.45M13.91%
2025-06-30$1.27M-31.53%
2025-03-31$1.85M-16.03%
2024-12-31$2.21M-6.04%
2024-09-30$2.35M-2.00%
2024-06-30$2.40M-0.33%
2024-03-31$2.41M8.72%
2023-12-31$2.21M641.41%
2023-09-30$298.48K1412.23%
2023-06-30$19.74K2043.11%
2023-03-31$921.00-60.74%
2022-12-31$2.35K104.00%
2022-09-30$1.15K-11.94%
2022-06-30$1.31K100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31--

bioAffinity generated $1.45M in revenue during Q3 2025, up 13.91% compared to the previous quarter, and up 60.30% compared to the same period a year ago.

bioAffinity Revenue Breakdown

bioAffinity Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 24Dec 23
Health Care, Patient Service$516.00K-
Health Care, Other-$19.32K
Other Revenues-$21.52K

bioAffinity's latest annual revenue breakdown by segment (product or service), as of Dec 24: Health Care, Patient Service (100.00%).

Quarterly Revenue by Product

Product/ServiceSep 25Jun 25Mar 25Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23
Other Revenues$258.00$4.38K$23.92K$23.92K$427.00----
Health Care, Patient Service$1.17M$2.51M$169.00K$248.65K-----
Health Care, Other---$50.14K$33.19K$16.06K$16.93K$2.39K-
Laboratory Services-------$7.42K-
Royalty Income-------$5.41K-
Diagnostic Test--------$7.00K

bioAffinity's latest quarterly revenue breakdown by segment (product or service), as of Sep 25: Health Care, Patient Service (99.98%), and Other Revenues (0.02%).

bioAffinity Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
WOKWORK Medical Technology Group$11.51M$3.10M
BIAFbioAffinity$9.36M$1.45M
MNDRMobile-health Network Solutions Class A Ordinary Shares$5.77M$3.32M
CARMCarisma Therapeutics--
GTBPGT Biopharma--
ARTLArtelo Biosciences--
REVBRevelation Biosciences--
PBMPsyence Biomedical--
PTIXProtagenic Therapeutics--
SLRXSalarius Pharmaceuticals--

BIAF Revenue FAQ

What is bioAffinity’s yearly revenue?

bioAffinity's yearly revenue for 2024 was $9.36M, representing an increase of 269.68% compared to 2023. The company's yearly revenue for 2023 was $2.53M, representing an increase of 52627.44% compared to 2022. BIAF's yearly revenue for 2022 was $4.8K, representing an increase of 100.00% compared to 2021.

What is bioAffinity’s quarterly revenue?

bioAffinity's quarterly revenue for Q3 2025 was $1.45M, a 13.91% increase from the previous quarter (Q2 2025), and a -38.47% decrease year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $1.27M, a -31.53% decrease from the previous quarter (Q1 2025), and a -47.06% decrease year-over-year (Q2 2024). BIAF's quarterly revenue for Q1 2025 was $1.85M, a -16.03% decrease from the previous quarter (Q4 2024), and a -22.94% decrease year-over-year (Q1 2024).

What is bioAffinity’s revenue growth rate?

bioAffinity's revenue growth rate for the last 3 years (2022-2024) was 194820.30%, and for the last 5 years (2020-2024) was 0%.

What are bioAffinity’s revenue streams?

bioAffinity's revenue streams in c 24 are Health Care, Patient Service

What is bioAffinity’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of bioAffinity was Health Care, Patient Service. This segment made a revenue of $516K, representing 100.00% of the company's total revenue.